Clinical TrialsSearch results
Number of results: 417
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A randomized phase 2 study assessing the efficacy and safety of levofloxacin added to the GEM/nabPTX combination therapy in patients with advanced pancreatic cancer(T-CORE2201)
- pancretic cancer
- Ishioka Chikashi
- 2023-05-19
Recruiting
- An evaluation of safety and efficacy of triamcinolone acetonide for preventing re-stenosis in endoscopic radial incision and cutting dilation
- benign stenosis of lower gastrointestinal tract
- Moroi Rintaro
- 2022-04-21
Recruiting
- A phase II study of ipilimumab, nivolumab, and radiotherapy for advanced NSCLC
- Non-small cell lung cancer
- Miyauchi Eisaku
- 2022-04-19
Recruiting
- Exploratory study to evaluate the efficacy and safety of tocilizumab for Takayasu's arteritis based on classification by type of autoantibody
- Takayasu's arteritis;TA
- Ishii Tomonori
- 2022-03-22
Recruiting
- Prospective study of 3D printing composite resin crown
- Dental caries, root canal treated tooth, ill-fitting crown
- Egusa Hiroshi
- 2022-02-21
Completed
- Clinical Study to Evaluate the Performance and Safety of AI-OR-001
- Ischemic Heart Disease
- Nasu Kenya
- 2022-01-14
Recruiting
- An exploratory clinical study on intermittent negative pressure chamber system in patients with critical limb ischemia
- Critical limb ischemia
- Ohura Norihiko
- 2022-01-05
Completed
- A Study of Maribavir in Japanese People with Cytomegalovirus (CMV) Infection
- Cytomegalovirus (CMV) Infection
- Nishizawa Atsushi
- 2021-11-28
Other
- Randomized , double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of belimumab for early systemic lupus erythematosus
- Systemic Lupus Erythematosus : SLE
- Ishii Tomonori
- 2021-10-14
Recruiting
- A rollover extension program (REP) to evaluate the long-term safety and tolerability of open label iptacopan in adult participants with primary IgA nephropathy
- IgA Nephropathy
- Yamada Hiroyuki
- 2021-10-12